Successful Treatment of Sinusitis by Acanthamoeba in a Pediatric Patient After Allogeneic Stem Cell Transplantation

Pediatr Infect Dis J. 2016 Dec;35(12):1350-1351. doi: 10.1097/INF.0000000000001329.

Abstract

Acanthamoeba infections are rare and mostly occur in immunocompromised patients. Most of the reported cases after stem cell transplantation have been diagnosed postmortem. We present the case of a 3-year-old boy with chronic graft versus host disease post hematopoietic transplantation, who was successfully treated for Acanthamoeba.

Publication types

  • Case Reports

MeSH terms

  • Acanthamoeba
  • Amebiasis* / complications
  • Amebiasis* / drug therapy
  • Amebiasis* / parasitology
  • Amebicides / therapeutic use
  • Amphotericin B / therapeutic use
  • Child, Preschool
  • Graft vs Host Disease / complications*
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Male
  • Nasal Mucosa / parasitology
  • Nasal Mucosa / pathology
  • Sinusitis* / complications
  • Sinusitis* / drug therapy
  • Sinusitis* / parasitology

Substances

  • Amebicides
  • Amphotericin B